The comprehensive examination of the mutational landscape of OAS1, OAS2, OAS3, and OASL genes in breast cancer patients revealed that OAS1, OAS3, and OASL exhibited an absence of mutations in all 986 analyzed breast cancer samples. This evidence concerns the gene OAS1 and breast carcinoma.